<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41765">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01777724</url>
  </required_header>
  <id_info>
    <org_study_id>5TK90 HAPPY</org_study_id>
    <secondary_id>U1111-1137-1053</secondary_id>
    <nct_id>NCT01777724</nct_id>
  </id_info>
  <brief_title>Evaluation of a Parenting and Stress Management Programmme</brief_title>
  <acronym>HAPPY</acronym>
  <official_title>Evaluation of a Parenting and Stress Management Programme: An Exploratory Randomised Controlled Trial of Triple P-Positive Parenting Program and Stress Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Research Council</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Greater Glasgow and Clyde</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical Research Council</source>
  <oversight_info>
    <authority>United Kingdom: National Health Service</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will use a randomised controlled trial design to evaluate the effects of a
      combined intervention of Triple P-Positive Parenting Program Discussion Groups and Stress
      Control in comparison to a waitlist condition. The combined intervention will be evaluated
      with parents in Glasgow, United Kingdom, with a 3-8 year old child.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in dysfunctional parenting practices as measured by the Parenting Scale</measure>
    <time_frame>Baseline, mid-intervention (approximately 4 weeks after baseline), post-intervention (approximately 12 weeks after baseline), 3-month follow-up (approximately 24 weeks after baseline)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measures dysfunctional parenting practices: laxness, overreactivity, and verbosity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in symptoms of depression, anxiety and stress as measured by the Depression Anxiety Stress Scales 21</measure>
    <time_frame>Baseline, mid-intervention (approximately 4 weeks after baseline), post-intervention (approximately 12 weeks after baseline), 3-month follow-up (approximately 24 weeks after baseline)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the frequency of disruptive child behaviours as measured by Eyberg Child Behavior Inventory-Intensity scale</measure>
    <time_frame>Baseline, post-intervention (approximately 12 weeks after baseline), 3-month follow-up (approximately 24 weeks after baseline)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measures parents' perceptions of their child's disruptive behaviour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in positive mental wellbeing as measured by the Short Warwick-Edinburgh Mental Well-being Scale</measure>
    <time_frame>Baseline, post-intervention (approximately 12 weeks after baseline), 3-month follow-up (approximately 24 weeks after baseline)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in parents' perceptions of their parenting experiences as measured by the Parenting Experience Survey</measure>
    <time_frame>Baseline, post-intervention (approximately 12 weeks after baseline), 3-month follow-up (approximately 24 weeks after baseline)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in parents' perceptions of their parenting self-efficacy as measured by the Child Adjustment and Parent Efficacy Scale-Parent Efficacy subscale</measure>
    <time_frame>Baseline, post-intervention (approximately 12 weeks after baseline), 3-month follow-up (approximately 24 weeks after baseline)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in parents' perceptions of their family relationships as measured by the Parenting and Family Adjustment Scale-Family Relationships subscale</measure>
    <time_frame>Baseline, post-intervention (approximately 12 weeks after baseline), 3-month follow-up (approximately 24 weeks after baseline)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Family demographics</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Demographic information of the participating families</description>
  </other_outcome>
  <other_outcome>
    <measure>Parents' satisfaction with the Triple P Discussion Groups and Stress Control, as measured by the Consumer Satisfaction Questionnaire developed for Triple P programmes, and the Consumer Satisfaction Questionnaire developed for Stress Control</measure>
    <time_frame>Post-intervention (approximately 12 weeks after baseline)</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>The fidelity of the intervention as measured by the Triple P Discussion Group session content checklists, and session content checklists for Stress Control that were developed for this study</measure>
    <time_frame>The practitioner/s delivering the intervention will complete a session content checklist after each Triple P Discussion Group and after each Stress Control session</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Parenting</condition>
  <condition>Parent Mental Health</condition>
  <condition>Child Behaviour Problems</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention is a combination of Triple P Discussion Groups and Stress Control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Waitlist control. Participants allocated to the waitlist control will be able to access the intervention after post-intervention equivalent measures have been completed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Combination of Triple P Discussion Groups and Stress Control</intervention_name>
    <description>The intervention consists of eight group sessions: two 120 minute Triple P Discussion Group sessions (http://www.triplep.net/), and six 90 minute Stress Control sessions (http://glasgowsteps.com/home.php).</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has a child aged between 3 and 8 years old

          -  Able to attend the group sessions held at Langside Halls, Shawlands in Glasgow,
             United Kingdom

          -  Able to read a newspaper without assistance

        Exclusion Criteria:

          -  Child has a diagnosis of a developmental or intellectual disability or other
             significant health impairment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marion Henderson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Research Council Social and Public Health Sciences Unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dr Marion Henderson, PhD</last_name>
    <phone>(+44) 141-357-3949</phone>
    <email>marion@sphsu.mrc.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melanie Palmer, BA (Hons)</last_name>
    <phone>(+44) 141-357-3949</phone>
    <email>mpalmer@sphsu.mrc.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Research Council Social and Public Health Sciences Unit</name>
      <address>
        <city>Glasgow</city>
        <zip>G12 8RZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion Henderson, PhD</last_name>
      <phone>(+44) 141-357-3949</phone>
      <email>marion@sphsu.mrc.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Melanie Palmer, BA (Hons)</last_name>
      <phone>(+44) 141-357-3949</phone>
      <email>mpalmer@sphsu.mrc.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Marion Henderson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Melanie Palmer, BA (Hons)</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.sphsu.mrc.ac.uk/</url>
    <description>Medical Research Council Social and Public Health Sciences Unit homepage</description>
  </link>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 19, 2013</lastchanged_date>
  <firstreceived_date>December 14, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical Research Council</investigator_affiliation>
    <investigator_full_name>Dr Marion Henderson</investigator_full_name>
    <investigator_title>Senior Investigator Scientist</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
